Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo
NCT00228462
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
197
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Seroquel (quetiapine)
Sponsor
AstraZeneca